Medication adherence: Whose responsibility is it anyway?
Pharmaceutical manufacturers should feel empowered to lead the charge and improve medication adherence as a way to prevent downstream problems that would impact their organizations.
Pharmaceutical manufacturers should feel empowered to lead the charge and improve medication adherence as a way to prevent downstream problems that would impact their organizations.
The pharmaceutical industry employs chief executive officers, chief financial officers, chief revenue officers and chief talent officers, but pharma has yet to employ a chief adherence officer, singularly tasked with going after pharma’s half-a-trillion-dollar revenue opportunity.
In addition to its collaboration deal with Walgreens, HealthPrize has begun to work with medical device companies to help patients learn to use products such as autoinjectors and respiratory devices.
The financing will be used primarily to expand the HealthPrize team to respond to its growing customer base in the U.S. as well as markets in Europe and Latin America, according to a company statement.
HealthPrize Technologies has inked a deal with West Pharmaceuticals that will expand the company’s medication adherence meets gaming technology to injectable drugs that are self-administered, according to a company statement. The injectable devices will use Bluetooth low energy wireless capability to convey to HealthPrize when someone has taken their latest dosage. It’s the first deal […]
Digital health company HealthPrize Technologies is expanding an incentive program to motivate medication adherence tool that offers points towards prizes in exchange for patient engagement. It is moving beyond pharmaceutical companies which have been the main client base since its platform launch in 2010. It wants to expand its customer base with employers and payers, […]
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
There’s getting patients to take their medications, and then there’s convincing big pharmaceutical companies that they should invest in innovative ways to try to get patients to take their medications. The latter, apparently, is more complicated than it sounds. That’s one thing I gleaned from a conversation with Tom Kottler, the CEO of a digital […]